Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Saetta

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Scandinavian Journal of Work, Environment & Health|October 1, 1994
CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanateP Maestrelli, G F Del Prete, M De Carli, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 1999
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary diseaseM Saetta, S Baraldo, L Corbino, et al.
The European Respiratory Journal|March 3, 2006
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitisF Guddo, A M Vignola, M Saetta, et al.
American Journal of Respiratory and Critical Care Medicine|December 31, 1997
Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitisR E Lucchini, F Facchini, G Turato, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 1996
Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanateC E Mapp, J R Lapa e Silva, R E Lucchini, et al.
The European Respiratory Journal|October 26, 2007
Increased activation of p38 MAPK in COPDT Renda, S Baraldo, G Pelaia, et al.
Thorax|July 30, 2004
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinomaA Papi, G Casoni, G Caramori, et al.
Thorax|February 6, 2002
Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokersD Miotto, M D Hollenberg, N W Bunnett, et al.
The European Respiratory Journal|July 22, 1999
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory SocietyK F Chung, P Godard, E Adelroth, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Scandinavian Journal of Work, Environment & Health|October 1, 1994
CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanateP Maestrelli, G F Del Prete, M De Carli, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 1999
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary diseaseM Saetta, S Baraldo, L Corbino, et al.
The European Respiratory Journal|March 3, 2006
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitisF Guddo, A M Vignola, M Saetta, et al.
American Journal of Respiratory and Critical Care Medicine|December 31, 1997
Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitisR E Lucchini, F Facchini, G Turato, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 1996
Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanateC E Mapp, J R Lapa e Silva, R E Lucchini, et al.
The European Respiratory Journal|October 26, 2007
Increased activation of p38 MAPK in COPDT Renda, S Baraldo, G Pelaia, et al.
Thorax|July 30, 2004
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinomaA Papi, G Casoni, G Caramori, et al.
Thorax|February 6, 2002
Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokersD Miotto, M D Hollenberg, N W Bunnett, et al.
The European Respiratory Journal|July 22, 1999
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory SocietyK F Chung, P Godard, E Adelroth, et al.
Pageof 11